Italia markets open in 7 hours 30 minutes

West Pharmaceutical Services, Inc. (WST)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
358,17-6,02 (-1,65%)
Alla chiusura: 04:00PM EDT
363,00 +4,83 (+1,35%)
Dopo ore: 05:24PM EDT

West Pharmaceutical Services, Inc.

530 Herman O. West Drive
Exton, PA 19341-1147
United States
610 594 2900
https://www.westpharma.com

Settore/iHealthcare
SettoreMedical Instruments & Supplies
Impiegati a tempo pieno10.600

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Eric M. GreenNon-Independent Chair of the Board, President & CEO2,9M45,4M1970
Mr. Bernard J. BirkettSenior VP & CFO1,39M6M1969
Mr. Silji AbrahamSenior VP & CTO972,09k4,64M1972
Ms. Kimberly Banks MacKaySenior VP, General Counsel & Company Secretary841,52kN/D1966
Ms. Cindy Reiss-ClarkSenior VP & Chief Commercial Officer879,48k452,64k1974
Mr. Chad R. WintersVP, Chief Accounting Officer & Corporate ControllerN/DN/D1979
Dr. Quintin J. Lai C.F.A., Ph.D.Vice President of Investor RelationsN/DN/D1967
Michele PolinskyVice President of Global CommunicationsN/DN/DN/D
Mr. Rudy PoussotSenior VP of Strategy & Corporate DevelopmentN/DN/DN/D
Ms. Annette F. FavoriteChief Human Resources Officer & Senior VP803,25kN/D1965
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Governance aziendale

L'ISS Governance QualityScore di West Pharmaceutical Services, Inc. al 1 maggio 2024 è 8. I criteri di valutazione fondamentali sono revisione: 8; Consiglio di Amministrazione: 8; diritti degli azionisti: 8; retribuzione: 4.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.